UK markets open in 7 hours 58 minutes
  • NIKKEI 225

    29,559.10
    +150.93 (+0.51%)
     
  • HANG SENG

    29,880.42
    +784.56 (+2.70%)
     
  • CRUDE OIL

    60.81
    -0.47 (-0.77%)
     
  • GOLD FUTURES

    1,707.70
    -8.10 (-0.47%)
     
  • DOW

    31,270.09
    -121.43 (-0.39%)
     
  • BTC-GBP

    36,280.27
    +1,750.19 (+5.07%)
     
  • CMC Crypto 200

    1,014.06
    +25.96 (+2.63%)
     
  • ^IXIC

    12,997.75
    -361.04 (-2.70%)
     
  • ^FTAS

    3,808.24
    +36.56 (+0.97%)
     

Insights on the Patient Controlled Injectors Global Market to 2027 - by Product, Application, Distribution Channel and Geography

Research and Markets
·8-min read

Dublin, Feb. 09, 2021 (GLOBE NEWSWIRE) -- The "Patient Controlled Injectors Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product; Application; Distribution Channel, and Geography" report has been added to ResearchAndMarkets.com's offering.

According to this report the global patient controlled injectors market is expected to reach $2,969.47 million by 2027 from $7,505.70 million in 2019. The market is estimated to grow at a CAGR of 12.4% from 2020 to 2027. The report highlights trends prevailing in the global patient controlled injectors market and the factors driving market along with those that act as hindrances.

Based on product, the global patient controlled injectors market is segmented into electronic wearable injector, mechanical wearable injector, and infusion pumps. In 2019, the electronic wearable injectors segment held the largest share of the market; whereas, the mechanical wearable injectors segment is estimated to register the highest CAGR in the market during the forecast period. Factors such as rising adoption of mechanical injectors and emphasis on superior treatment outcomes are estimated to contribute to the mechanical wearable injectors segment growth.

The growth of the patient controlled injectors market is attributed to the factors such as increasing prevalence of chronic conditions and acceptance of patient controlled injectors due to better patient compliance. However, lack of awareness and adoption of patient controlled injectors in emerging countries is likely to restraint the growth of the market during the forecast period.

The demand for patient controlled injectors increased during the pandemic period. Factors such as increased patient population, shortage of healthcare resources, and ease of increased the adoption of injectors had positive impact on the market by certain extent. However, implementation of physical distancing policies and total shut down of businesses in order to prevent the viral infection disrupted the supply chain operations, which caused a negative impact on the market growth.

Gerresheimer AG; F. Hoffmann-La Roche Ltd.; Johnson and Johnson Services, Inc.; Ypsomed AG; Westbourne Medical Limited; Enable Injections; scPharmaceuticals Inc.; United Therapeutics Corporation; and BD are among the leading companies operating in the patient controlled injectors market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the patient controlled injectors market.

  • Highlights key business priorities in order to assist companies to realign their business strategies.

  • The key findings and recommendations highlight crucial progressive industry trends in the global patient controlled injectors market, thereby allowing players across the value chain to develop effective long-term strategies.

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Key Topics Covered:

1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Global Patient Controlled Injectors Market - By Product
1.3.2 Global Patient Controlled Injectors Market - By Application
1.3.3 Global Patient Controlled Injectors Market - By Distribution Channel
1.3.4 Global Patient Controlled Injectors Market - By Geography

2. Patient Controlled Injectors Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Global Patient Controlled Injectors Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East & Africa - PEST Analysis
4.2.5 South & Central America - PEST Analysis
4.3 Expert Opinion

5. Patient Controlled Injectors Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Chronic Diseases
5.1.2 Rising Patient Compliance
5.2 Market Restraints
5.2.1 Lack of Adoption in Emerging Countries
5.3 Market Opportunities
5.3.1 Technological Advancements and Design Development
5.4 Future Trends
5.4.1 Consolidation of Market
5.5 Impact Analysis

6. Patient Controlled Injectors Market - Global Analysis
6.1 Global Patient Controlled Injectors Market Revenue Forecast and Analysis
6.2 Global Patient Controlled Injectors Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players

7. Patient Controlled Injectors Market - By Product
7.1 Overview
7.2 Patient Controlled Injectors Market Share, by Product, 2019 and 2027 (%)
7.3 Electronic Injectors
7.3.1 Overview
7.3.2 Electronic Injectors: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
7.4 Mechanical Injectors
7.4.1 Overview
7.4.2 Mechanical Injectors: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
7.5 Infusion Pumps
7.5.1 Overview
7.5.2 Infusion Pumps: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)

8. Patient Controlled Injectors Market - By Application
8.1 Overview
8.2 Patient Controlled Injectors Market Share, by Application, 2019 and 2027 (%)
8.3 Cancer Treatment
8.3.1 Overview
8.3.2 Cancer Treatment: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
8.4 Autoimmune Disease
8.4.1 Overview
8.4.2 Autoimmune Disease: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
8.5 Blood Disorders Treatment
8.5.1 Overview
8.5.2 Blood Disorder Treatment: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)

9. Patient Controlled Injectors Market - By Distribution Channel
9.1 Overview
9.2 Patient Controlled Injectors Market Share, by Distribution Channel, 2019 and 2027 (%)
9.3 Hospital Pharmacies
9.3.1 Overview
9.3.2 Hospital Pharmacies: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
9.4 Retail Pharmacies
9.4.1 Overview
9.4.2 Retail Pharmacies: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
9.5 Mail Order Pharmacies
9.5.1 Overview
9.5.2 Mail Order Pharmacies: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)

10. Patient Controlled Injectors Market - Geographic Analysis
10.1 North America: Patient Controlled Injectors Market
10.2 Europe: Patient Controlled Injectors Market
10.3 Asia Pacific: Patient Controlled Injectors Market
10.4 Middle East & Africa: Patient Controlled Injectors Market
10.5 South and Central America: Patient Controlled Injectors Market

11. Impact Of COVID-19 Pandemic on Global Patient Controlled Injectors Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment Of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Patient Controlled Injectors Market - Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview

13. Company Profiles
13.1 West Pharmaceutical Services, Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Sensile Medical AG (Gerresheimer AG)
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 F. HOFFMANN-LA ROCHE LTD.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Johnson and Johnson Services, Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Ypsomed AG
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Westbourne Medical Limited
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Enable Injections
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 scPharmaceuticals Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 United Therapeutics Corporation
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 BD
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix
14.1 About the Publisher
14.2 Glossary of Terms

For more information about this report visit https://www.researchandmarkets.com/r/kmczkw

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900